NCT05556824: Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD |
|
|
| Recruiting | 2 | 156 | US | MHS-1031, Panosyl-isomaltooligosaccharide, Placebo | Microbiome Health Sciences, VBHRC Virginia Catalyst | Gastroesophageal Reflux | 07/25 | 07/25 | | |